NeuroPace (NPCE) Tops Q3 EPS by 8c, provides guidance

NeuroPace (NASDAQ: NPCE) reported Q3 EPS of ($0.19), $0.08 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $21.1 million versus the consensus estimate of $19.07 million.

GUIDANCE:

NeuroPace sees FY2024 revenue of $78-80 million, versus the consensus of $77.097 million.

representing growth of 19% to 22% over 2023, an increase from the $76 million to $78 million range set last quarter
Gross margin to range between 72% and 74%
Total operating expenses to range between $80 million and $84 million, including approximately $10 million in stock-based compensation, a noncash expense

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c